YASHVIN ONKARAPPA MANGALA

Allopathic & Osteopathic Physicians|Internal Medicine PROVIDENCE, RI NPI 1184100992

General Payments — all program years on this page

$5,176.21

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 76
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $656.52 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $556.5315
Education $99.991

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $183.765
2019 $639.307
2020 $319.678
2021 $822.8113
2022 $1,348.2715
2023 $1,205.8812
2024 $656.5216

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078858308 Janssen Scientific Affairs, LLC $57.98 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078858342 Janssen Scientific Affairs, LLC $25.94 06/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086122078 Bayer Healthcare Pharmaceuticals Inc. $14.12 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087335283 Novartis Pharmaceuticals Corporation $26.91 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087335293 Novartis Pharmaceuticals Corporation $20.16 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089464614 Daiichi Sankyo Inc. $17.67 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093964701 Alexion Pharmaceuticals, Inc. $28.01 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101081745 Celgene Corporation $29.93 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105155451 ABBVIE INC. $86.36 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105740852 AstraZeneca Pharmaceuticals LP $18.71 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110789566 Eisai Inc. $17.53 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121191773 ADC Therapeutics America, Inc. $150.00 12/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128609361 Kite Pharma, Inc. $23.96 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131527496 ARRAY BIOPHARMA INC $22.49 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131583167 ARRAY BIOPHARMA INC $16.76 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141227722 Incyte Corporation $99.99 04/02/2024 Education Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.